Dura Substitute Market to Grow at a CAGR of 5.9% from 2022 to 2030

20 Jul 2022
www.biospace.com
IPO
The global dura substitute market was valued at US$ 175.6 Mn in 2022 and is estimated to expand at a CAGR of 5.9% from 2022 to 2030 The global dura substitute market is expected to reach the value of US$ 328.6 Mn by the end of 2030 Analysts’ Viewpoint on Dura Substitute Market Scenario Healthcare providers in the dura substitute market are increasing efforts to improve the quality of life for patients with musculoskeletal disorders amid the ongoing coronavirus pandemic. It has been found that xenografts could cause complications such as graft disintegration, encapsulation, and scarring in patients. Hence, healthcare companies should increase R&D in regenerative medicine to overcome complications of xenografts. Download Sample @ Manufacturers are increasing the production of FDA-approved degradable materials such as biomimetic patch made of poly-L-lactic acid, which holds promising potentials to improve patient outcomes. Researchers have attempted to employ various synthetic polymers to make dural substitutes in order to minimize the spread of diseases caused by the use of allogeneic or xenogeneic materials for increasing clinical effectiveness and reduce costs. Rise in Number of Neurological Treatments Triggering Demand for Dura Substitutes The high prevalence of CNS (Central Nervous System) tumors caused by neurological disorders is emerging as a driver for companies in the dura substitute market. Chiari malformation and spinal cord related neurosurgery procedures are fuelling the demand for dura substitutes. The rise in the number of neurological treatments, such as duraplasty, is triggering the demand for dura substitutes. It has been found that in 2018, more than half of all dural substitutes were utilized in cranial and spine tumor surgeries. Healthcare Companies Increasing Availability of Grafts During Coronavirus Pandemic Healthcare services have been affected due to the ongoing coronavirus pandemic. Elective procedures have been postponed indefinitely in the dura substitute market. Neurosurgeons are being redeployed to treat COVID-19 patients. Recent cases of the Omicron variant are creating concerns for healthcare providers. Since coronavirus affects the brain of individuals, participants in the dura substitute market are improving their healthcare services to enable better patient outcomes. There is a requirement of compulsory training to the neurosurgeon community to understand the symptoms of the novel infection. As such, participants in the market are increasing the availability of biological grafts & synthetic grafts to ensure continuity in healthcare services. They are increasing efforts to revive R&D activities to gain proficiency in neurosurgical and spinal surgeries. R&D Investment and Regenerative Medicine Hold Potentials to Improve Surgical Outcomes Complications associated with dura substitute materials are affecting market growth. For instance, autologous tissue is generally preferred for commercialized dura replacements as it reduces the chances of infection and rejection. However, if there is insufficient local replacement tissue of sufficient quality to heal the dural defect, surgeons may avoid autografts. Hence, investments in R&D for materials and government initiatives to promote regenerative medicine hold promising potentials to improve surgical procedures. Since governments across the world are realizing the importance of regenerative medicine, such trends are translating into revenue opportunities for companies in the dura substitute market. Quick Buy This Premium Report From Here: Government Funding in Regenerative Medicine Contributing to Market Growth Government funding for the treatment of various diseases is increasing globally due to the formulation and adoption of supporting legislation & policies. Such trends are contributing to expansion of the regenerative medicine sector in the dura substitute market. Healthcare companies are drawing significant expenditure in regenerative medicines such as the establishment of centers of excellence, manufacturing infrastructure, and research networks, among others. The NIH (National Institutes of Health) Common Fund facilitated the establishment of the NIH Center for Regenerative Medicine in 2010 with the purpose of serving as a national resource for stem cell sciences. Such developments are helping to accelerate the development of novel medical applications and cell-based therapeutics. Transition from Animal Tissue-derived Materials to Synthetic Materials Aiding Market Growth Dural repair materials are transitioning from animal tissue-derived materials to synthetic materials as well as from inert to absorbable properties. Such findings are bringing a significant change in the global dura substitute market. Biomimetic patch is a new dural repair product that provides functional properties similar to alternate therapies. This patch has a 3 dimensional (3D) non-woven microfiber structure that is both mechanically strong and biocompatible. The animal investigation revealed that the biomimetic patch and commercially synthesized material groups demonstrated new subdural regeneration after 90 days, with low inflammatory response and minimal to no adhesion development at each stage. It has been found that the biomimetic structure and proper rate of degradation of the new absorbable dura replacement can lead significant regeneration of the dura mater. Dura Substitute Market: Overview Dural substitute is a type of medical device used in surgeries to repair dura mater, the outermost layer that covers and protects the brain. Animal collagen or nanofibers woven together with an elastic material to form a soft tamponade can also be used to create a dural substitute. Dural substitutes are required to prevent CSF leaks and to allow dural openings to heal after surgery. Dural substitutes can be biological or synthetic, harvested from animals or human cadavers, and used as an onlay or suturable grafts. The key advantage of using a dural substitute is that it is similar to the patient’s dura and can absorb and integrate into the host tissue. Rise in the number of road accidents and sports injuries, which increases the need of neurosurgery, is the major factor boosting market growth. However, product recalls is likely to hamper market growth. Dura Substitute Market: Key Drivers Prevalence of CNS tumors caused by neurological disorders is increasing. Chiari malformation and spinal cord tumor-related neurosurgery procedures that necessitate dural grafts have become more common. Rise in prevalence of neurological diseases requires neurosurgical treatments as well as duraplasty for effective and safe treatment outcomes. In 2018, more than half of all dural substitutes were utilized in cranial and spine tumor surgeries. This is expected to continue in the near future. Therefore, rise in prevalence of neurosurgical diseases leads to an increase in cranial and spinal duraplasty procedures, which in turn is anticipated to boost the demand for dura substitutes. Researchers have attempted to employ various synthetic polymers to make dural substitutes in order to minimize the spread of diseases caused by the use of allogeneic or xenogeneic materials, increase clinical effectiveness, and reduce costs Synthetic macromolecular materials, in comparison to collagen-based dura substitutes, lack the biological functions of stimulating cell migration and boosting the production of related cytokines. Scientists have attempted to create dura substitutes by incorporating gelatin or silk fibroin into the polymer. This approach not only assures the bionic structure of the dural replacement, but also enhances the material’s biological function and surface properties, improving its repair effects. Therefore, benefits such as enhanced clinical effectiveness, increased safety, and minimal adverse effects associated with synthetic dura substitutes are anticipated to fuel the growth of the dura substitute market Market Segmentation: Dura Substitute Market In terms of material, the global dura substitute market has been bifurcated into biological graft and synthetic graft. The biological graft segment has been split into autografts, allografts, and xenografts. The synthetic segment has been segregated into polytetrafluoroethylene and others. Based on application, the global dura substitute market has been classified into neurosurgery and spinal surgery In terms of end-user, the global dura substitute market has been divided into hospitals, ambulatory surgical centers, and others Each of the segments has been analyzed in detail for market trends, recent trends, and developments, drivers, restraints, opportunities, and useful insights. The dura substitute market report provides current and expected revenue (US$ Mn) for each of these segments from 2021 to 2031, considering 2020 as the base year. The compound annual growth rate (percentage CAGR) has been provided for each segment and market from 2021 to 2031 along with market size estimations. Regional Overview: Dura Substitute Market In terms of region, the global dura substitute market has been segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa North America dominated the global dura substitute market in 2020, accounting for 41.8% share. Developed healthcare infrastructure and presence of patient-specific healthcare systems fuel the growth of the dura substitute market in North America. The U.S. dominated the market in North America due to rapid adoption of new technologies for soft tissue repair, presence of key players, and higher penetration of research activities across the country Moreover, growing burden of neurosurgical diseases is leading to increase in cranial and spinal duraplasty, which, in turn, is likely to boost the demand for dura substitute in the region Major Players The dura substitute market report concludes with the company profiles section, which includes key information about major players in the global dura substitute market Leading players analyzed in the report include Cook Medical LLC B. Braun Melsungen AG Integra LifeSciences Cousin Surgery W. L. Gore & Associates, Inc. Biosynth Lifesciences Acera Surgical, Inc. Medprin Medtronic Stryker DePuy Synthes Gunze Limited Baxter Bennett Health, Inc. RTI Surgical Natus Medical Incorporated Each of these players has been profiled in the dura substitute market report based on parameters such as company overview, financial overview, business strategies, application portfolio, business segments, and recent developments Key Questions Answered in Global Dura Substitute Market Report What is the sales/revenue generated by dura substitute procedure across all regions during the forecast period? What are the opportunities in the global dura substitute market? What are the major drivers, restraints, opportunities, and threats in the market? Which regional market is set to expand at the fastest CAGR during the forecast period? Which segment is expected to generate the highest revenue globally in 2031? Which segment is projected to expand at the highest CAGR during the forecast period? What are the market positions of different companies operating in the global market? Segmentation Material Biological Grafts Synthetic Grafts Application Neurosurgery Spinal Surgery End-user Hospitals Ambulatory Surgical Centers Others Region North America Europe Asia Pacific Latin America Middle East & Africa Quick Buy This Premium Report From Here: You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333 About Us QYResearch Medical, focuses on custom research, management consulting, IPO consulting, industry chain research, and data base & seminar services. The company owns large basic databases (such as National Bureau of Statistics Database, Customs Import and Export Database, Industry Association Database, etc.), expert resources (including industry experts who own more than 10 years experiences on marketing or R&D in industries of healthcare services, medical technology & devices, etc.), professional survey team (the team members obtained more than 3 years market survey experience and more than 2 years deep expert interview experience), and excellent data analysis team (SPSS statistics and PPT graphics process team). QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover China, US, EU, Asia, Middle East and Africa, South America, Australia, and other regions in the world. For Latest Update Follow Us: URL –
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-
Drugs
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.